Joint Task Force to Counter Illicit Synthetic Narcotics Act of 2025
Summary
What This Bill Does
The bill creates congressional findings documenting the opioid crisis affecting hundreds of thousands of Americans, fragmented government response across multiple levels, and absence of a central coordinating entity, defines definitions of controlled substance, listed chemical, Director, illicit synthetic narcotic (excluding natural substances and lawfully imported medications), and JTF-ISN, and establishes JTF-ISN with multi-agency membership (DOJ/DEA/FBI, Treasury/FinCEN/OFAC, DHS/CBP/ICE/Coast Guard, State, Commerce, Defense, ODNI), presidentially appointed Senate-confirmed Director at Executive Schedule. It relies on compliance mandates, reporting requirements, exemptions, and definition changes. The main policy areas are Criminal Justice, Civil Rights, Immigration, and Finance.
Who Benefits and How
Personal drug users could face lower compliance burdens, Low-level drug dealers not connected to trafficking networks could face lower compliance burdens, and Federal law enforcement agencies could gain revenue opportunities.
Who Bears the Burden and How
Narcotics trafficking organizations and money launderers could face higher costs, Illicit synthetic narcotics trafficking networks could face higher costs, and Illicit fentanyl trafficking networks could face higher costs.
Key Provisions
- Creates congressional findings documenting the opioid crisis affecting hundreds of thousands of Americans, fragmented government response across multiple levels, and absence of a central coordinating entity.
- Defines definitions of controlled substance, listed chemical, Director, illicit synthetic narcotic (excluding natural substances and lawfully imported medications), and JTF-ISN.
- Establishes JTF-ISN with multi-agency membership (DOJ/DEA/FBI, Treasury/FinCEN/OFAC, DHS/CBP/ICE/Coast Guard, State, Commerce, Defense, ODNI), presidentially appointed Senate-confirmed Director at Executive Schedule...
- Requires primary mission directing counter-opioid and synthetic narcotics disruption, joint operations, raids, tactical actions, sanctions enforcement, and legal actions against traffickers and foreign entities...
- Requires broad investigative and prosecutorial authority over narcotics trafficking, money laundering, smuggling, false statements, and related offenses.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill creates congressional findings documenting the opioid crisis affecting hundreds of thousands of Americans, fragmented government response across multiple levels, and absence of a central coordinating entity, defines definitions of controlled substance, listed chemical, Director, illicit synthetic narcotic (excluding natural substances and lawfully imported medications), and JTF-ISN, and establishes JTF-ISN with multi-agency membership (DOJ/DEA/FBI, Treasury/FinCEN/OFAC, DHS/CBP/ICE/Coast Guard, State, Commerce, Defense, ODNI), presidentially appointed Senate-confirmed Director at Executive Schedule.
Key Policy Areas
Criminal Justice, Civil Rights, Immigration, Finance
Primary Purpose
The bill creates congressional findings documenting the opioid crisis affecting hundreds of thousands of Americans, fragmented government response across multiple levels, and absence of a central coordinating entity, defines definitions of controlled substance, listed chemical, Director, illicit synthetic narcotic (excluding natural substances and lawfully imported medications), and JTF-ISN, and establishes JTF-ISN with multi-agency membership (DOJ/DEA/FBI, Treasury/FinCEN/OFAC, DHS/CBP/ICE/Coast Guard, State, Commerce, Defense, ODNI), presidentially appointed Senate-confirmed Director at Executive Schedule.
Policy Domains
Sec. 2-3 -- Findings and Definitions
Identified Gains
- Personal drug users
- Low-level drug dealers not connected to trafficking networks
- Federal law enforcement agencies
- Lawful pharmaceutical importers with DEA permits
- State and local law enforcement
Identified Costs
- Narcotics trafficking organizations and money launderers
- Illicit synthetic narcotics trafficking networks
- Illicit fentanyl trafficking networks
- Foreign nationals outside the US involved in drug trafficking
- Chinese chemical precursor suppliers
Sponsors
Legislative Progress
In CommitteeMr. McCormick (for himself, Mr. Coons, Mrs. Britt, and Mr. …
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Department of Homeland Security border agencies, Department of the Treasury counter-narcotics units, Drug Enforcement Administration
Positive-direction: Federal law enforcement agencies, State and local law enforcement
Negative-direction: JTF-ISN Director and staff
Foreign nationals outside the US involved in drug trafficking, Illicit fentanyl trafficking networks, Illicit synthetic drug manufacturers and traffickers
Low-level drug dealers not connected to trafficking networks, Personal drug users
Lawful pharmaceutical importers with DEA permits
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_director"
- → Director of JTF-ISN (presidentially appointed, Senate-confirmed)
- "the_attorney_general"
- → Attorney General
- "the_director"
- → Director of JTF-ISN
- "the_director"
- → Director of JTF-ISN
Key Definitions
Terms defined in this bill
As defined in section 102 of the Controlled Substances Act (21 U.S.C. 802).
The Director of the JTF-ISN.
A controlled substance (excluding natural origin substances and lawfully imported medications with DEA permits), a listed chemical, or an active pharmaceutical ingredient or chemical used in production of a controlled substance or listed chemical.
The Joint Task Force to Counter Illicit Synthetic Narcotics established under section 4.
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology